Abstract
INTRODUCTION
The practice of environmental protection often applies biotechnology for the elimination of various contaminants such as hydrocarbons. However, the widespread application of biotechnological processes requires not only the effectiveness of these methods, but to keep occupational hazards, public health concerns and environmental risks on an acceptable level [1] . Despite these requirements, we can still the hospital settings without any clear predisposing factor [14] that emphasizes the increasing importance of environmental strains. The comparison of phylogenetic profiling with additional features such as serotyping, genotyping and antibiotic resistance can help us to see the major factors playing a role in the evolutionary trends of environmental P. aeruginosa [13] . Considering the possible occupational hazards on bioremediated sites, another urging issue is to clarify the direct concerns for human health of these environmental strains. Testing of animals is still the most reliable way to give information on infectious, invasive and toxic features of these strains. Therefore, the main aims of this paper have been to evaluate the phylogenetic positions of 2 multidrug resistant P. aeruginosa strains (P43 and P69) isolated from hydrocarbon contaminated natural environments with MLST profiling, to give a complex evaluation of MLST data complemented with several virulence markers (hemolytic activity, and the presence of exoA, exoU, exoS, exoT, exoY encoding gene sequences) and to examine in vivo virulence with the determination of LD 50 (the lethal dose, 50%) values in an intraperitoneal mouse model. As additional information, the hydrocarbon degradation abilities of the isolated strains have also been determined.
MATERIAL AND METHODS Sampling
The examined strains of P. aeruginosa (strain collection signs P43 and P69) were isolated from environmental samples of 2 hydrocarbon contaminated sites located in Hungary, where soil and groundwater were periodically monitored. The main properties of the examined contaminated sites and samples are summarized in the Table 1 . Soil and groundwater samples were taken in accordance with the relevant Hungarian Standards [15, 16] under aseptic conditions. The isolated P. aeruginosa strains are presumably the members of indigenous microbiota and were able find examples of the application of unidentified [2] , or opportunistic microorganisms [3] for bioremediation purposes, such as Pseudomonas aeruginosa, a Gram-negative, rod shaped bacterium that is widely known as a nosocomial pathogen with serious concerns for human health [4, 5] . With respect to its wide catabolic potential [6] and ubiquitous features, environmental strains of P. aeruginosa are commonly applied for the remediation of inorganic [7] and organic [8] contaminants that possibly lead to its increasing influence on the microbial ecosystem of remediated sites. The occupational and public health concerns of this practice are still unclear, since the examined features of a strain applied for bioremediation purposes usually don't overlap with clinically important characteristics. Some evidence suggests that environmental isolates of P. aeruginosa species are able to show multidrug resistant features [9] and to form biofilms [10] , carry several virulence markers [11] but to give a more comprehensive estimation, phylogenetic investigations are proposed. Phylogenetic characterization (such as pulsed-field gel electrophoresis (PFGE), random amplification of polymorphic DNA (RAPD), multilocus sequence typing (MLST) profiling) of P. aeruginosa is increasingly applied for the evaluation of genetic relations among strains isolated from various environments [12] . The recent opinion suggests that P. aeruginosa species exhibits a nonclonal epidemic population structure, where clinical isolates cannot be distinguished from environmental strains [13] . As an evidence of the strong connection between clinical and environmental strains, it has been concluded that while major clonal strains of P. aeruginosa isolated from cystic fibrosis (CF) patients are presumably spread person-to-person, unique and minor clonal strains (that are responsible for the minority of P. aeruginosa infection of CF patients) are acquired from natural environmental sources [12] . Moreover, in some cases P. aeruginosa infections such as community-acquired pneumonia (CAP) can occur outside Concentrations (MICs) were determined by Etest (AbBiodisk, Solna, Sweden). Altogether 20 agents of 5 classes were examined, out of which 10 are the first choice for clinical therapy of P. aeruginosa. The implementation and evaluation were based on the recommendations of the Clinical Laboratory Standards Institute [20, 21] and the instructions of the manufacturer (AbBiodisk). Pseudomonas aeruginosa ATCC 27853 was the reference strain. Multidrug resistance was concluded in the case of simultaneous resistance against 2 or more classes of the examined antibiotics [22] .
Multilocus sequence typing (MLST)
Phylogenetic investigation was based on the multilocus sequence typing scheme with the detection and sequencing of 7 housekeeping genes and followed the recommended instructions [23, 24] . Primer sequences of the polymerase chain reaction (PCR) based detection are detailed in the Table 2 . Reaction parameters were 98°C, 3 min, 30× (95°C, 1 min; 55°C, 1 min; 72°C, 1 min) 72°C, 10 min. Amplicons were purified with the MinElute UF PCR Purification Kit (Qiagen) in accordance with the manufacturer's instructions. Nucleotide sequences were determined with the BigDye Terminator (version 3.1) Cycle Sequencing Ready Reaction Kit to reach detectable cell counts by the way of their ability to adapt to hydrocarbon contamination.
Isolation and identification of P. aeruginosa
Isolation, identification and enumeration of P. aeruginosa species followed the protocol of the relevant Hungarian Standard [18] with most probable number (MPN) enumeration on selective and differential media. The identification was confirmed with the PCR for the detection of species specific variable regions V2 and V8 of 16S rDNA [19] . The preparation of DNA was done with the FastDNA TM kit (Qbiogene 6540-400)
following the manufacturer's instructions. Primer sequences were F: 5'-GGGGGATCTTCGGACCTCA-3' and R: 5'-TCCTTAGAGTGCCCACCCG-3', reaction parameters were 95°C, 2 min, 25× (94°C, 25 s; 58°C, 40 s; 72°C, 40 s) 72°C, 1 min.
Antibiotic resistance
Multidrug resistant features of environmental P. aeruginosa strains P43 and P69 were presumed on the basis of a previously published investigation [9] . In the present work, the range of the examined antibiotics was supplemented with 10 further antibiotic agents. Minimal Inhibitory [28] .
In vivo virulence investigations in a mouse model
Investigations on in vivo virulence of the environmental strains were conducted at the Experimental Center of the Central Agricultural Office (Gödöllő, Hungary) in accordance with the relevant national and using the following parameters: 96°C, 1 min, 30× (95°C, 10 s; 51°C, 5 s; 60°C, 2 min). Unincorporated dye terminators were removed with 95% ethanol precipitation, and reaction products were separated with the ABI Genetic Analyzer Model 3100 (Applied Biosystems). Sequences were assembled by DNA Baser (version 3.0) (Heracle BioSoft). Allelic profiles and sequence types (STs) were determined as it was recommended [25] .
Virulence markers
The examined virulence markers were hemolytic activity on Columbia Blutagar (Heipha Diagnostica) with incubation parameters recommended by the manufacturer (37°C, 22 h), and the detection of toxic protein encoding gene The intraperitoneal injection of mice groups was prepared with 0.2 ml of bacterial suspensions of P. aeruginosa strains P43 and P69. The magnitudes of test concentrations were 10 3 , 10 5 and 10 7 colony forming units (CFU) per 1 ml, respectively; the exact CFU values were determined with agar plate count method. The negative control was a non-inoculated test group. Based on the scientific literature, the applied concentrations were applicable for the determination of lethal doses of P. aeruginosa species [32] , but were low enough to differentiate the pathogenic effect from non-specific immune responses. After experimental infection, the clinical symptoms, such as general condition, behavior, movement coordination, disorders in the nervous system and body weight were documented in the 1st and 4th h and then every 24 h for 14 days.
At the end of the experiment, test animals were sacrificed to examine macroscopic changes of gastro-intestinal tract, cardiovascular system, lungs, liver, lien and kidneys.
international regulations on animal experiments and the Organisation for Economic Co-operation and Development (OECD) guidelines [29] . Test animals were NMRI line, Specific Pathogen Free (SPF), female albino mice with 18.9-23 g body weight (Charles River Hungary Ltd.), that were randomly separated into groups of 5. Care was given under usual circumstances with ad libitum watering, VRF-1 mouse chow (Charles River Hungary Ltd.) and an ambient temperature of 22±3°C. Growth conditions of the examined bacterial strains were based on the recommended instructions [30, 31] . The investigated multidrug resistant environmental isolates of P. aeruginosa (P43 and P69) were spread on tryptic soy agar (CASO, Merck 105458) and were incubated in 37°C for 18 h. After incubation, the bacterial suspensions of identical colonies were prepared in physiological saline (0.85%), with the turbidity equivalent to 0.5 McFarland (bioMérieux), and were serially diluted to reach the experimental concentrations. 508 among the sampled environmental microbiotas (Table 4) . Therefore, we can assume that P. aeruginosa speciesis a notable constituent of the microbial community in the examined hydrocarbon contaminated samples.
Hydrocarbon degradation ability
Based on our investigations, both of the examined environmental strains are able to use hydrocarbon compounds as a solo carbon source and are able to degrade dieselcrude oil components at 87.4% (P43) and 62.8% (P69) efficiency. As these results suggest, the indigenous strains of P. aeruginosa are able to adapt to hydrocarbon contaminations and to reach outstanding hydrocarbon degradation rates in vitro.
Multilocus sequence typing (MLST)
The application of an MLST scheme on environmental P. aeruginosa isolates led to the detection of 2 known sequence types, ST253 in the case of the strain P43 and ST439 in the case of the strain P69 (Table 5) . Based on the database of Pseudomonas aeruginosa MLST Database [24] , these STs were previously identified in the cases of both the environmental and the clinical isolates of P. aeruginosa. The identified sequence type ST253 belongs to the well-revealed PA14 clonal complex and was previously detected in the case of strains originated from various samples such as soil [23] , sputum of a CF patient [12] , bronchial lavage, or urinary tract The chance of septicaemia was checked with surface spread plate method of blood, originated from heart puncture, on cetrimide agar (37°C, 24 h). The lethal dose, 50% values were determined in the basis of Miller-Tainter method [33] .
Hydrocarbon degradation ability
The hydrocarbon decomposing ability was determined with a simple, semiquantitative gravimetry measurement using an inoculated mineral medium containing 2 ml of a 3:2 mixture of diesel oil and crude oil. After 120 h incubation, residual hydrocarbon compounds were recovered with chloroform/petroleum ether extraction following the previously described protocol [34] and were compared to a non-inoculated control incubated under the same conditions.
RESULTS
The microbial properties of the examined samples are summarized in the Table 4 and the characteristic features of the isolated environmental strains of P. aeruginosa, such as: MLST profiles, sequence types (STs), antibiotic resistance and virulence features are shown in the Table 5 .
The main properties of the examined environmental strains
The comparison of total bacterial cell counts and the MPN numbers of hydrocarbon degrading bacteria and P. aeruginosa of groundwater samples suggests that the examined species is able to reach a considerable rate [20] . ** Previously published [9] and are classified as first choice agents in clinical therapy of P. aeruginosa. *** "+++" -intensive hemolysis; "++" -normal hemolysis; "+" -moderate hemolysis; "-" -no hemolysis. **** "+" -positive polymerase chain reaction (PCR) reaction; "-" -negative PCR reaction. Gray shading indicates antibiotic resistance (R), and all positive results.
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510 that these strains are capable of playing a role in infection of CF patients.
Antibiotic resistance investigations
Based on our antibiotic resistance investigations, the isolated environmental strains of P. aeruginosa show antibiotic resistance against Penicillins and third generation Cephalosporins of Cephems (cefotaxime, ceftriaxone, ceftazidime) with the exception of the combination of cefoperazone-sulbactam and the fourth generation Cephalosporin (cefepime). Aminoglycosides were completely ineffective against the strain P43, but they were effective in the case of the strain P69. Among Fluoroquinolones, the antibiotic resistance was detectable only in one case (P69 against ofloxacin). Other antibiotics, such as the examined Folate (trimethoprim), Phenicol (chloramphenicol), Lipopeptide (polymyxin B) and Tetracycline (tetracycline) antibiotic agents had no effect on the examined strains except for polymyxin B. Based on these results, the multidrug resistant features can be confirmed both in the case of P43 and P69 and the multiple resistance mechanisms are presumed.
Virulence markers investigations
Based on virulence markers assay, both of the examined strains show hemolytic activity, and carry gene sequences encoding the production of toxic proteins exoA, exoY, and infection. The geographic locations of these detections were completely different, since 4 out of the above mentioned sources were located in Europe (UK, Hungary, and Poland), while one of the isolated strains originated from Australia. Therefore, it is presumed that P43 is a member of a globally successful clonal complex of P. aeruginosa. The identified sequence type ST439 of strain P69 was previously described in samples originated from a Cystic Fibrosis Clinic, France.
The neighbor-joining analysis of the detected STs (generated with the European Molecular Biology Open Software Suite (EMBOSS) web tool of Pseudomonas aeruginosa MLST Database [24] with STs of ≥ 4 matches) are summarized in the Figure 1 and the Figure 2 . The analysis of the available background information of STs with the closest relation to strain P43 (ST253) shows that the neighboring strains of ST828 are originated from CF patients, while others, such as ST109, ST107 and ST104 related to O10 or O11 serotype, out of which O11 is described as dominant among clinical isolates of P. aeruginosa [36] . In the case of P69 (ST439) the available information is limited, but the isolated strains with the same ST suggest As it can be seen, the injection of bacterial suspensions had serious and concentration dependent effects on body weight directly following the first 24 h period that can be attributed to a decreased intake of food. Further weighing showed a steady (4.6-16.35%) lag in body weights (Figure 3) in comparison with the control group that can be exoT. A different pattern was obtained in the presence and absence of exoU and exoS genes; exoU gene sequence was detectable in the case of strain P43, while exoS gene sequence was identified in the case of strain P69. Based on scientific literature, the expression of effector protein exoS is associated with colonization and invasive features, while exoU is related to increased virulence and cytotoxicity [37] . Therefore, strain P43 can be classified as cytotoxic isolate, while P69 can bring into connection with invasive features.
In vivo virulence investigations
Based on the agar plate count method, the formed groups of test animals (P43/1, P43/2, P43/3 and P69/1, P69/2, P69/3) were inoculated with the serially diluted bacterial suspensions of strains P43 and P69. The relevant doses are shown in the Table 6 . The short and long term changes in weight values are summarized in the Table 6 and the Figure 3 , where experimental groups P43/3 and P69/3 are not involved since due to the 100% mortality of test animals in 24 h. caused by P. aeruginosa species [38] . In our work, the presence of the exoS gene, a main contributor of successful colonization of CF lungs [13] , was identified in the case of environmental strain P69, while exoU, a cytotoxic factor was identified in the genome of strain P43. ) [45, 46] . Considering the typical pathways of environmental and occupational exposures to microorganisms, such as attributed to the long-term negative effects of infectious materials on general status of test animals. Based on necropsy, the typical clinical symptom of bacterial injection was splenomegaly detectable in 35% of the examined test animals. Septicaemia was established in the case of test animals that perished before the end of the 14-day experiment (members of groups P43/3, P69/3 and P69/2), since infectious material was re-isolable from their blood culture. The heart puncture of surviving individuals of group P43/1, P43/3, P69/1 and P69/2 did not show the signs of septicaemia. The rates of lethality in correlation with infectious doses led to the determination of LD 50 values of 5.37×10
5 CFU (strain P43) and 7.07×10 5 CFU (strain P69), respectively.
DISCUSSION
Based on our multiplex analysis of 2 environmental originating strains of P. aeruginosa (P43 and P69), a complex dataset became available with regard to phylogenetic relations, antibiotic resistance and virulence features, hydrocarbon degrading ability and genotypes. This complex estimation follows the suggested trends for the examination of opportunistic species such as P. aeruginosa [13] and may fill in the gap experienced in the field of environmentally originated strains. The multilocus sequence typing of the examined isolates led to the detection of 2 known STs (ST253 and ST439), which have had previously been identified among strains, both in clinical and environmental surroundings [23] . Some of the isolated strains related to these phylogenetic categories had notable influence upon the infection of CF patients [12] . This strong, phylogenetic relation corroborates the connection between the environmental strains and those that have importance to the infection of CF patients. inhalation, swallowing or the injury of physical barriers, and with regards to special circumstances of hydrocarbon contaminated sites, where the aim is to increase the populations of hydrocarbon degrading microorganisms to levels > 10 5 CFU×g -1 cells in dry solids [47] , the presence or direct application of P. aeruginosa strains for bioremediation purposes, with the characteristic features discussed above, pose a considerable health risk.
CONCLUSIONS
Based on our multiplex analysis of several features, the investigated environmental strains of P. aeruginosa are not just theoretically able to cause disease: MLST profiles of environmental isolates P43 and P69 are strongly related to those that play roles in infection (mainly of cystic fibrosis patients), environmental strains commonly carry gene sequences that are important in pathogenesis, cause notable lethality in the applied mouse model, moreover, retain their hydrocarbon degrading ability. In summary, we can conclude that the human health hazard of a P. aeruginosa strain cannot be determined based on the knowledge of clinical or environmental source. The practice of isolating microorganisms from environmental sources for bioremediation purposes solely on the basis of their hydrocarbon decomposing activity is not a proper method to ensure the environmental and occupational safety of biotechnological processes. The parallel investigation on further clinically important features of the applied microorganisms and the exclusion of opportunistic species constitutes an urgent issue of environmental, occupational and public health.
